Cytogenetics of Iris Melanomas: Disparity with Other Uveal Tract Melanomas

Scotto, 1976, Melanomas of the eye and other non-cutaneous sites, J Natl Cancer Inst, 56, 489, 10.1093/jnci/56.3.489 Egan, 1988, Epidemiologic aspects of uveal melanoma, Surv Ophthalmol, 32, 239, 10.1016/0039-6257(88)90173-7 Rones, 1958, The prognosis of primary tumors of the iris treated by iridectomy, Arch Ophthalmol, 60, 193, 10.1001/archopht.1958.00940080207003 Sunba, 1980, Tumours of the anterior uvea I. Metastasizing malignant melanoma of the iris, Arch Ophthalmol, 98, 82, 10.1001/archopht.1980.01020030084004 Prescher, 1990, Non-random chromosomal abnormalities in primary uveal melanoma, J Natl Cancer Inst, 82, 1765, 10.1093/jnci/82.22.1765 Sisley, 1990, Cytogenetic findings in six posterior uveal melanomas, Genes Chromosom Cancer, 2, 205, 10.1002/gcc.2870020307 Sisley, 1992, Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma, Genes Chromosom Cancer, 5, 197, 10.1002/gcc.2870050304 Horsman, 1993, Cytogenetic analysis of uveal melanoma. Consistent occurrence of monosomy 3 and trisomy 8q, Cancer, 71, 811, 10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F Wiltshire, 1993, Cytogenetic analysis of posterior uveal melanoma, Cancer Genet Cytogenet, 66, 47, 10.1016/0165-4608(93)90148-F Singh, 1994, Cytogenetic findings in primary uveal melanoma, Cancer Genet Cytogenet, 72, 109, 10.1016/0165-4608(94)90125-2 Prescher, 1995, Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation, Cancer Genet Cytogenet, 80, 40, 10.1016/0165-4608(94)00165-8 White, 1995, Cytogenetic characterization of an iris melanoma, Cancer Genet Cytogenet, 82, 85, 10.1016/0165-4608(94)00217-Y Gosden CM, Davidson C, Robertson R (1992): Lymphocyte culture. In: Human Cytogenetics A Practical Approach. Volume I Constitutional Analysis. Second edition. DE Rooney, BH Czepulkowski, eds. IRL Press, Oxford University Press, Oxford, pp. 31–54. Ohta, 1996, Deletion mapping of chromosome region 9p 212-p22 surrounding the CDKN2 locus in melanoma, Int J Cancer, 65, 762, 10.1002/(SICI)1097-0215(19960315)65:6<762::AID-IJC9>3.0.CO;2-X ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel. Mitelman F (1994): Data base of cancer cytogenetics; An overview. In: Catalog of Chromosome Aberrations in Cancer. F. Mitelman, ed. Wiley Liss, Inc., New York, pp. ix–xviii. Hecht, 1990, A guide to fragile site on human chromosomes, Cancer Genet Cytogenet, 44, 37, 10.1016/0165-4608(90)90195-G Sokova, 1992, Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas, Cancer Genet Cytogenet, 58, 24, 10.1016/0165-4608(92)90128-U Ohta, 1996, The FHIT gene, spanning chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers, Cell, 84, 587, 10.1016/S0092-8674(00)81034-X Walker, 1994, Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions, Oncogene, 9, 819 Healy, 1995, Loss of heterozygosity in sporadic primary cutaneous melanoma, Genes Chromosom Cancer, 12, 152, 10.1002/gcc.2870120211 Kamb, 1994, A cell cycle regulator potentially involved in genesis of many tumor types, Science, 264, 436, 10.1126/science.8153634 Prescher, 1996, Prognostic implications of monosomy 3 in uveal melanoma, Lancet, 347, 1222, 10.1016/S0140-6736(96)90736-9 Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer. Wiley Liss, Inc., New York. Robertson, 1996, Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6, Cancer Res, 56, 1635